Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Oberwaldner Beatrice |

Presentations at scientific and public conferences

Eber, E; Mitterhuber, A; Oberwaldner, B; Zach, M THE SIX-MINUTE WALK TEST AND LUNG FUNCTION IN CYSTIC FIBROSIS PATIENTS
PEDIAT PULM. 2009; 404--23rd Annual North American Cystic Fibrosis Conference; Oct 15-17, 2009; Minneapolis, USA. [Poster]
Web of Science

Mitterhuber, A; Oberwaldner, B; Eber, E; Zach, M The six-minute walk test in cystic fibrosis: a comparison to lung function.
Supplement 53 of the European Respiratory Journal2009; 34: 403s--19th Annual Congress of the European Respiratory Society (ERS); SEPT 12-16, 2009; Vienna, Austria. [Poster]

Thalhammer, G; Eber, E; Oberwaldner, B; Dacar, D; Zach, M Totally impantable venous access devices in patients with cystic fibrosis.
European Respiratory Journal2008; 32 (Supplement 52): 217--Annual Congress of the European Respiratory Society; OCT 10, 2008; Berlin, GERMANY. [Oral Communication]

Eber, E; Oberwaldner, B; Dacar, D; Zach, M Erfahrung mit vollständig implantierbaren venösen Kathetersystemen bei Patienten mit zystischer Fibrose.
Atemwegs- und Lungenkrankheiten . 2004; 30: 146-147.-26. Jahrestagung der Gesellschaft für Pädiatrische Pneumologie; MAR 25-27, 2004; Hamburg, GERMANY. [Poster]

Eber, E; Oberwaldner, B; Dacar, D; Zach, M Totally implantable venous access devices in patients with cystic fibrosis.
Journal of Cystic Fibrosis 2003; 2 (Suppl. 1): S72--26th European Cystic Fibrosis Conference; JUN 4-7, 2003; Belfast, UK. [Poster]

Eber, E; Oberwaldner, B; Dacar, D; Zach, MS Experience with totally implantable venous access devices in cystic firbrosis patients.
European Respiratory Journal 2003; 22 (Suppl. 45): 502s--Annual Congress 2003 of the European Respiratory Society; Sept. 27 - Oct. 1, 2003; Vienna, AUSTRIA. [Oral Communication]

Pfleger, A; Oberwaldner, B; Zach, MS Pädiatrische Aspekte der Langzeitheimbeatmung - Standards des Zentrums Graz.
Wiener Klinische Wochenschrift -Education. 2003; 115: 898-900.

Eber, E; Benesch, M; Oberwaldner, B; Koczulla, AR; Weiss, R; Zach, MS Management of tracheobronchomalacia by long-term continuous positive airway pressure.
American Journal of Respiratory and Critical Care Medicine 2001; 163: A31--97th International Conference of the American Thoracic Society; MAY 18-23, 2001; San Francisco, USA. [Poster]

Eber, E; Heinzl, B; Oberwaldner, B; Zach, MS Inhaled anti-pseudomonal prophylaxis in cystic fibrosis.
The Netherlands Journal of Medicine. 1999; 54 (Suppl.): S37--23rd European Cystic Fibrosis Conference; JUN 9-12, 1999; The Hague, THE NETHERLANDS. [Poster]

Heinzl, B; Oberwaldner, B; Eber, E; Zach, M Inhalative Anti-Pseudomonas-Prophylaxe bei zystischer Fibrose.
Abstraktband der Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde. 1999; -37. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; SEPT24, 1999; Linz, AUSTRIA. [Poster]

Winklhofer-Roob, BM; Sitzwohl, B; Waeg, G; Steinbrugger, B; Eber, E; Pfleger, A; Oberwaldner, B; Malle, E; Zach, M Immunological evidence of oxidative protein modifications by 4-hydroxynonenal and hypochlorous acid in sputum of patients with cystic fibrosis (CF).
FASEB J. 1999; 13: A701-A701. [Poster]
Web of Science

Winklhofer-Roob, BM; Sitzwohl, B; Waeg, G; Steinbrugger, B; Eber, E; Pfleger, A; Oberwaldner, B; Malle, E; Zach, MS Oxidative protein modifications induced by 4-hydroxy-2,3-trans-nonenal and hypochlorous acid are present in bronchial secretions of patients with cystic fibrosis (CF).
Pediatric Pulmonology. 1999; 19 (Suppl.): 307-308.-13th North American Cystic Fibrosis Conference; OCT 7-10, 2011; Seattle, USA. [Poster]

Oberwaldner, B; Eber, E; Weiss, R; Zach, M Langzeit-CPAP als nicht-chirurgisches Behandlungsprinzip bei kongenitaler Tracheo- und Bronchomalazie.
Monatsschrift Kinderheilkunde. 1995; 143: 219--17. Jahrestagung der Gesellschaft für Pädiatrische Pneumologie; MAR 16-18, 1995; Davos, SWITZERLAND. [Oral Communication]

Zach, MS; Eber, E; Oberwaldner, B Airflow obstruction and airway wall instability in cystic fibrosis (CF): the isolated and combined effect of theophylline and sympathomimetics.
American Review of Respiratory Disease. 1987; 135 (4 - part 2): A287--Annual Meeting of the American Thoracic Society; MAY 10-13, 1987; New Orleans, USA. [Poster]

Eber, E; Oberwaldner, B; Zach, MS Airflow obstruction and airway wall instability in cystic fibrosis (CF): the isolated and combined effect of theophylline and sympathomimetics.
Abstractband. 1986; -14th Annual Meeting of the European Working Group for Cystic Fibrosis; SEPT 1-2, 1986; Budapest, HUNGARY. [Oral Communication]

Eber, E; Oberwaldner, B; Zach, MS Luftwegsobstruktion und Bronchialinstabilität bei zystischer Fibrose (CF): Der variable Einfluss von isolierter und kombinierter Theophyllin- und Sympathomimetikatherapie.
Abstractband. 1986; -8. Jahrestagung der Gesellschaft für Pädiatrische Pneumologie; MAY 22-24, 1986; Wien, AUSTRIA. [Oral Communication]

ZACH, MS; OBERWALDNER, B; EVANS, JC FORCED EXPIRATIONS AGAINST AN EXPIRATORY RESISTANCE IMPROVE MUCUS CLEARANCE AND LUNG-FUNCTION IN CHILDREN WITH CYSTIC-FIBROSIS (CF)
AMER REV RESP DIS. 1986; 133(4): A248-A248.
Web of Science

ZACH, M; OBERWALDNER, B PHYSICAL EXERCISE AS A SUBSTITUTE FOR THE INHALATION-PHYSIOTHERAPY ROUTINE IN CYSTIC-FIBROSIS
EUR J PEDIAT. 1982; 138(1): 94-94.
Web of Science

↑ Top of page / Navigation